Borg Anneli, Holm Mikael, Shiroyama Ikue, Hauryliuk Vasili, Pavlov Michael, Sanyal Suparna, Ehrenberg Måns
From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and 3H Biomedical AB, Dag Hammarskjölds Väg 34A, Uppsala Science Park, 751 83 Uppsala, Sweden.
From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
J Biol Chem. 2015 Feb 6;290(6):3440-54. doi: 10.1074/jbc.M114.611608. Epub 2014 Dec 1.
The antibiotic fusidic acid (FA) targets elongation factor G (EF-G) and inhibits ribosomal peptide elongation and ribosome recycling, but deeper mechanistic aspects of FA action have remained unknown. Using quench flow and stopped flow experiments in a biochemical system for protein synthesis and taking advantage of separate time scales for inhibited (10 s) and uninhibited (100 ms) elongation cycles, a detailed kinetic model of FA action was obtained. FA targets EF-G at an early stage in the translocation process (I), which proceeds unhindered by the presence of the drug to a later stage (II), where the ribosome stalls. Stalling may also occur at a third stage of translocation (III), just before release of EF-G from the post-translocation ribosome. We show that FA is a strong elongation inhibitor (K50% ≈ 1 μm), discuss the identity of the FA targeted states, and place existing cryo-EM and crystal structures in their functional context.
抗生素夫西地酸(FA)作用于延伸因子G(EF-G),抑制核糖体肽链延伸和核糖体循环,但FA作用的更深层次机制仍不清楚。利用蛋白质合成生化系统中的淬灭流动和停流实验,并利用受抑制(10秒)和未受抑制(100毫秒)延伸循环的不同时间尺度,获得了FA作用的详细动力学模型。FA在转位过程的早期阶段(I)靶向EF-G,药物的存在并不阻碍其进行到后期阶段(II),此时核糖体会停滞。停滞也可能发生在转位的第三个阶段(III),就在EF-G从转位后核糖体释放之前。我们表明FA是一种强效延伸抑制剂(K50%≈1μm),讨论了FA靶向状态的特性,并将现有的冷冻电镜和晶体结构置于其功能背景中。